Organogenesis Holdings (ORGO) Margins & Profitability 2020-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 45.9%
EBITDA Margin: -108.2%
Op. Margin: -116.5%
Net Margin: -220.0%

Op. margin of -116.5% is down 104.1% YoY — costs are rising relative to revenue. Net margin at -220.0% and gross margin of 45.9% show how much of each revenue dollar survives to profit.

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit